Back
C4 Therapeutics 10K Form
Sell
24
CCCC
C4 Therapeutics
Last Price:
6.87
Seasonality Move:
19.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CCCC News And Ratings
See the #1 stock for the next 7 days that we like better than CCCC
CCCC Financial Statistics
Sales & Book Value
Annual Sales: | $20.76M |
---|---|
Cash Flow: | $-5.17M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.59 |
Price / Book: | 1.79 |
Profitability
EPS (TTM): | -1.90000 |
---|---|
Net Income (TTM): | $-107.87M |
Gross Margin: | -- |
Return on Equity: | -44.9% |
Return on Assets: | -28.94% |
C4 Therapeutics Earnings Forecast
Key C4 Therapeutics Financial Ratios
- The Research & Development expenses have been 567.09% of Revenue.
- The Interest Expense is -1.04% of Operating Income.
- The Net Earning history of CCCC is -638.34% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 2 years.
C4 Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | CCCC |
CUSIP: | 12529R |
Website: | c4therapeutics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.09 |
Quick Ratio: | 4.89 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CCCC Technical Analysis vs Fundamental Analysis
Sell
24
C4 Therapeutics (CCCC)
is a Sell
Is C4 Therapeutics a Buy or a Sell?
-
C4 Therapeutics stock is rated a Sell
The current C4 Therapeutics [CCCC] share price is $6.39. The Score for CCCC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.